Furthermore, analysis of ID gene expression in an AML patient cohort showed that high levels of ID gene expression were correlated with FLT3-ITD, RAS, EVI-1 and C/EBPA mutations, suggesting ID gene expression may be induced downstream of oncogene activated signal transduction pathways (111). This evidence concerns the gene FLT3 and acute myeloid leukemia.